AKT1 and familial pancreatic carcinoma: PTEN was reported to be down-regulated in pancreatic cancer cell lines and targets NF-kappaB and c-Myc by activating PI3K/Akt signaling pathway, thereby exerting a role in inhibiting pancreatic cancer (Asano et al., 2004; Ying et al., 2011).